Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-17

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot trial studies how well a diabetes prevention program with or without hunger training works in helping to lower breast cancer risk in obese participants. A diabetes prevention program involves learning about and receiving materials on different strategies to encourage weight loss, and hunger training involves learning how to recognize hunger. It is not yet known whether adding hunger training to a diabetes prevention program helps participants control their weight that could reduce the risk of some cancers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of a Low Glycemic Index Diet on Breast Density

NCT01237938

Breast Cancer

TERMINATED NA

Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk

NCT01559194

Breast Cancer Weight Loss

COMPLETED PHASE3

Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women

NCT00470119

Breast Cancer Obesity Weight Changes

COMPLETED NA

A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women

NCT06635005

Feasibility Pilot Study Compliance

RECRUITING NA

Effect of Mindful Eating on Weight Management in Breast Cancer Survivors

NCT03972540

Breast Neoplasm Female

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Determine the feasibility of adding hunger training to the Diabetes Prevention Program (DPP) using the following criteria: accrual rates \> 50%, attrition rates \< 20% and, in the DPP-plus-hunger training (HT) group, training protocol adherence rates \> 75%.

SECONDARY OBJECTIVES:

I. Estimate the magnitude of effect sizes and variation in outcome variables for the DPP-only and DPP-plus-HT interventions on changes in weight; in metabolic and breast cancer risk biomarkers (e.g., fasting insulin and blood glucose \[BG\] levels, levels of glycosylated hemoglobin, insulin resistance, adiponectin, interleukin-6, and C-reactive protein); and in proposed behavioral mediators (e.g., reduction in total energy intake, overall eating frequency, percent of eating events occurring at or below the average fasting blood BG level).

II. Examine the mediation effects of proposed mechanisms of the interventions related to individual-level behavioral measures of eating self-regulation on the proposed outcomes using a multimodal approach of validated questionnaires and reliable ecological momentary assessment method.

OUTLINE: Participants are randomized to 1 of 2 groups.

GROUP A: Participants take part in DPP once a week over 1 hour for 16 weeks.

GROUP B: Participants take part in DPP once a week over 1 hour for 16 weeks and hunger training once a week during weeks 2-6.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deleterious BRCA1 Gene Mutation Deleterious BRCA2 Gene Mutation Ductal Breast Carcinoma In Situ Obesity Overweight Premalignant Lesion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A (DPP)

Participants take part in DPP once a week over 1 hour for 16 weeks.

Group Type ACTIVE_COMPARATOR

Behavioral, Psychological or Informational Intervention

Intervention Type OTHER

Take part in DDP

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Group B (DPP-HT)

Participants take part in DPP once a week over 1 hour for 16 weeks and hunger training once a week during weeks 2-6.

Group Type EXPERIMENTAL

Behavioral, Psychological or Informational Intervention

Intervention Type OTHER

Take part in DDP

Behavioral, Psychological or Informational Intervention

Intervention Type OTHER

Take part in HT

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral, Psychological or Informational Intervention

Take part in DDP

Intervention Type OTHER

Behavioral, Psychological or Informational Intervention

Take part in HT

Intervention Type OTHER

Questionnaire Administration

Ancillary studies

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body Mass Index (BMI) \>= 27 kg/m\^2.
* At high risk of developing breast cancer defined by one or more of the following: Gail model lifetime risk \> 20% or a 5 year risk \>1.66%, a history of deleterious BRCA1/2 mutation or mantle radiation, a history of ductal cancer in situ, or a history of high risk premalignant breast lesion.
* 12 months without a period/menstrual cycle or having had a bilateral oophorectomy.
* Ability to take digital time stamped photos.
* Internet access (daily).
* Reports being proficient in English (can read/write and speak fluently).

Exclusion Criteria

* Previous participation in this trial. Participation is defined as screening. Re-screening is not allowed except for individuals excluded for BMI. Patients previous screened as ineligible due to BMI are allowed to be re-screened and enrolled if eligible.
* Has a current measured BMI less than 27 kg/m\^2.
* Reports being unwilling to use Continuous Glucose Monitor (CGM), which requires daily blood sampling by finger pricks.
* Currently being actively treated for cancer other than nonmelanoma skin cancer.
* Known inability to participate in the ongoing appointments for the four months of the study and scheduled follow-up tests.
* Reported current diagnosis or history of type I diabetes or type 2 diabetes.
* Reported use of oral antidiabetic agents (OADs).
* Current use of any drug (except metformin) or anticipated change in concomitant medication, which the investigator's opinion could interfere with the glucose metabolism (e.g. systemic corticosteroids).
* Previous or current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin (short term treatment due to intercurrent illness including gestational is allowed at the discretion for the investigator).
* Previous or current treatment with GLP-1 receptor agonists (e.g. exenatide, liraglutide).
* Fasting blood glucose level \> 126 and glycosylated hemoglobin (HbA1c) \> 7%.
* Subjects considered by the investigator as unsuitable for the study for reasons not otherwise stated.

Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes